Cephalon sues to protect cancer drug Treanda

19-03-2014

Cephalon sues to protect cancer drug Treanda

Photo: Sun Pharmaceutical Industries Ltd

Teva-owned subsidiary Cephalon has sued Sun Pharma, claiming the Mumbai-based firm infringed a patent protecting its Treanda (bendamustine hydrochloride) product.


Cephalon, Treanda, Sun Pharma, Teva, ANDA

More on this story

Fed Circ upholds Teva cancer drug patents
17-08-2021

LSIPR